What’s New

Precision Business Insights

Expert Operating System Webinar Series – Recording

GeniusLink’s Expert Operating System allows companies to operate with better information, at a faster pace, with better results. This episode of the Expert oS Webinar Series, Outcomes as a Service: Precision Business Insights, premier partner 10EQS showcases how GeniusLink clients obtain precision unique business insights—on demand.

Learn More: View the webinar recording below:


Disrupt but Don’t Dismantle: The Invenia ABUS 2.0 Story

When it comes to change, complacency and fear of the unknown often encourage operating within the confines of previous experiences. Sometimes, a simple shift is perspective can lead to new possibilities.

For the last few months, GeniusLink has been working with Tanya Carrillo of GE Healthcare to stir up new research possibilities in the field of breast imaging and breast health. Tanya is the research manager for GE’s Invenia ABUS 2.0  (Automated Breast Ultrasound) device, a relative newcomer to the breast cancer screening field that’s showing lots of promise.

Invenia ABUS 2.0 is approved by the FDA to supplement mammography screenings for women with dense breast tissue. Mammograms use X-rays to capture images of the breast. Mammography images show low density tissue – such as fat – as translucent, while showing dense tissue – including connective and glandular tissue and tumors – as white. As Tanya explained, “For women with dense breast tissue, locating a tumor can be like trying to find a snowball in a snowstorm.” Ultrasound technology provides clinicians with a different view. Ultrasound “sees” dense tissue as white, while cancer appears black, providing a better opportunity for early diagnosis.

Additional imaging after a mammogram can be offered to women who have dense breasts (approximately 40 percent of women1). Supplemental imaging offers additional security for women with dense breasts to help ensure potential masses hiding in dense tissue on a mammogram are found sooner. As one of those supplemental options, Invenia ABUS 2.0 uses 3D ultrasound to capture a highly detailed view of the breast. According to GE’s research and the FDA’s Summary of Safety and Effectiveness, Invenia ABUS 2.0 has been shown to improve breast cancer detection by 35.7 percent over mammography alone, mainly revealing small, invasive and node negative cancers2.

As GE Healthcare builds the case for Invenia ABUS 2.0 supplemental imaging, Tanya knows that one of the technology’s biggest assets are those who have and continue to see its impact – current users. GE works with these users to compile and extract clinical evidence. Interestingly, Tanya pointed out that the early adopters of ABUS have not been the big academic medical centers usually seen doing research – instead adoption is being driven by individual breast imagers who are looking for a solution for their patients with dense breasts.

“We have an extremely passionate user base that possesses valuable data, but regional hospitals and women’s clinics aren’t approaching us to pitch their research ideas or applying for grant funding. Their time is spent with their daily clinical practice and in the community helping women,” Tanya said. “We needed a progressive approach to get them involved in research, which is why we turned to GeniusLink.”

GeniusLink partnered with Tanya and the Invenia ABUS 2.0 marketing team to craft an innovative challenge in the form of two calls for proposals (CFP). The first CFP aimed to engage and motivate current users to perform retrospective data review on a topic of their choosing related to automated breast ultrasound. The second CFP, which recently stopped accepting proposals, sought to engage users and non-users by soliciting prospective research related to automated breast ultrasound; basically, what research would you perform if you had an Invenia ABUS 2.0 system? The second CFP garnered an unprecedented 45 entries, for more on the second CFP here.

For both CFPs, GeniusLink developed a detailed communication and outreach strategy including email and social templates, online promotional banners, a website, the initial vetting process for submissions, and winner announcement support. The entire plan has been co-executed by the GeniusLink and Invenia ABUS 2.0 marketing teams.

“It is amazing to see these two teams come together and deliver in their areas of expertise,” said Tanya. “Our marketing team knows the product, the user base, and can gain traction among the industry’s influential organizations while GeniusLink knows how to position for innovation, invigorate a crowd, and disrupt but not dismantle.”

Our collective effort has delivered some pretty amazing results. The first CFP garnered 16 submissions, five of which were selected to receive up to $25,000 USD each in grant funding. The announcement took place at a high profile ABUS user event in September, which was part of the strategy to attract attention and increase interest. It’s important to note that the original plan was to award four grants, but Tanya and the GE Healthcare team were so impressed with the topics and users that they included a fifth.

“We were pleasantly surprised that some of our users were willing to go back and explore their data to correlate on such intricate topics; it speaks volumes about their passion for women’s health and their desire to advance an industry,” said Tanya. “And even for the more obvious topics, choosing was difficult because varying regional factors means the same research performed in two countries produce very different results.”

First round CFP winners are from the United States, Japan, China, and Switzerland. Their projects are currently being finalized and work will commence in the coming weeks. Second round winners will be announced on November 25, at a GE Healthcare research event during the Radiological Society of North America (RSNA) conference in Chicago, IL. Tanya and the GE Healthcare team are excited to review the new set of submissions and look forward to being surprised – yet again – by the proposed topics.

“Our goals with this research are to show the value of our automated breast ultrasound system, have that value recognized, and to see widespread adoption of ultrasound as part of breast cancer screening guidelines,” said Tanya. “Our relationship with GeniusLink is helping us create a strong foundation to achieve our goals and I look forward to continuing our relationship throughout this journey.”

For more information on how you can put GeniusLink to work for you, click here or contact me.


  1. Pisano et al. Diagnostic Performance of Digital versus Film Mammography for Breast -Cancer Screening. NEJM 2005;353:1773
  2. FDA PMA P110006 summary of safety and effectiveness.
In Good Company: The 2018 Optimal Aging Challenge

Informational Webinar and Q&A Session


Do you have a product, service or idea that could decrease loneliness and increase engagement among the aging population? Are you curious to learn more about the types of ideas being sought out and how to create a submission?

Please join us for an In Good Company informational webinar on September 6, 2018 from 10:00 a.m. to 11:00 a.m. ET.


You can expect to:

  • Learn about changing demographics around the world, what that means for your community, and the criticality of enriching the aging experience;
  • Learn about In Good Company: The 2018 Optimal Aging Challenge and its mission, as well as how Challenge Sponsors will work with winners to reduce social isolation and loneliness and increase engagement among older populations;
  • Hear about submission criteria, creating entry, types of ideas, and more;
  • Ask Challenge Sponsors questions and receive feedback that will help you refine your submission!

We hope you can join us!  Click here to register for the webinar!


What is In Good Company: The 2018 Optimal Aging Challenge?

The 2018 Optimal Aging Challenge seeks to highlight the criticality of enriching the aging experience—and act as a collaboration platform to solicit ideas, breakthrough technologies, services, community resources, and other solutions to reduce social isolation and loneliness and increase engagement among older populations.  Learn more here.

Have additional question about the Challenge?

View the In Good Company Challenge FAQ’s here.

Subject to Official Rules [].  Must submit at least one Entry by no later than 5pm EST on Sept 28, 2018 to be eligible. Must be 18 years of age or older to participate.  No purchase necessary.  Void where prohibited.  Up to 4 cash awards (USD $5,000 total each).  Winning depends on Entrant’s skills in meeting judging criteria.  Sponsors reserve right to limit or not award all prizes depending on quality of Entries received.

The HeadHealthTECH VI webinar recording is available here.

HeadHealthTECH Challenge VI sponsors—Dr. Barry Myers, Director of Innovation at Duke University’s Clinical and Translational Science Institute (Duke CTSI), and Jennifer Langton, Vice President of Health and Safety at the National Football League (NFL)— hosted the information webinar on August 14th.  Also featured were past Challenge winners, demonstrating how this program acts as a catalyst to accelerate each winner’s innovation and commercial success—as well as how they channeled feedback from unsuccessful submissions into winning results.

As Dr. Thom Mayer, MD, FACEP, FAAP, the Medical Director of the NFL Players Association, also shared helpful advice encouraging innovators to take advantage of the expertise and feedback from Dr. Myers and his team at Duke CTSI by submitting an idea to the challenge: “[Your] ideas that seemingly might not fit exactly as you might think… [are part of] a catalytic reaction. Your ability to communicate across boundaries—particularly under the magical influence of [Dr. Myers] can make a difference.

Langton added that even if you have just the beginning stages of a concept, please submit: “The feedback, networking and connections that Dr. Myers and his team provide can help bring your idea to the next level.

Thinking you have an interesting solution (even if just an idea) that could help advance player safety? HeadHealthTECH Challenge VI proposals are being accepted now through September 13th, 2018. Learn more about the series here.


The NFL recently hosted a webinar featuring Dr. Richard Kent, an engineering expert who works at the intersection of biomechanics and sports, and Jennifer Langton, NFL Vice President of Health and Safety Initiatives—to share a new toolkit designed to  encourage innovation and advance designs of new and improved protective sports equipment.  Read more about the toolkit and finite element (FE) models here.

NOW AVAILABLE: A New Engineering Resource for Football Helmet Design

As shared during the webinar (which you can view the recording of here), this new toolkit is now available to the public as a platform and baseline resource for injury prevention research and to stimulate the development of novel and highly effective helmet designs and prototypes. The open-source toolkit includes FE models of four modern football helmets, impact test dummy components, and test conditions simulating on-field impacts.

FE models are computational tools developed by breaking an object down into simpler parts (finite elements) and assembling them into a larger system of equations to model an entire structure—this facilitates the efficient analysis of design changes to that structure. FE models have been used to improve designs in many engineered products, including those in the aeronautics and automotive industries.

GET STARTED: Download Models & Learn More

With more data available on the types of impacts that cause head injuries, the engineering design of helmets and other protective equipment can be more targeted.  We encourage all innovators and  entrepreneurs who are working to develop effective helmet designs to explore the toolkit.


Learn More about the Engineering Roadmap

As part of the NFL’s Play Smart. Play Safe. initiative, the NFL pledged $60 million toward the creation and funding of a five-year project called the Engineering Roadmap, funded by the NFL and managed by Football Research, Inc. (FRI). The project, executed in collaboration with Biocore LLC, aims to improve the understanding of the biomechanics of head injuries in professional football and to create incentives for helmet manufacturers, small businesses, entrepreneurs, universities and others to develop and commercialize new and improved protective equipment, including helmets. Developing FE models for football helmets is just one of many ways that FRI is sharing research, data, tools and information to crowdsource and stimulate innovation. Additional resources:

TECH Challenge V is open now through June 6th, 2018—click here to learn more and submit a proposal.

Dr. Kent is a Professor of Mechanical & Aerospace Engineering, Biomedical Engineering and Emergency Medicine at the University of Virginia, past Deputy Director of the UVA Center for Applied Biomechanics, Co-Founder of Biomechanics Consulting & Research, LLC (Biocore) and a consultant to the NFL Health and Safety Committee.

Today’s successful operating system depend on the diversity of its people and expertise, seamless and effective processes, and digital platforms that make it easy to get business done.

As GE GENIUSLINK continues to expand its global network of experts, announcing its partnership with Fulcra, LLC.  This enterprise crowdfunding and innovation network allows companies to accelerate product development through idea generation, prototyping, market validation and more.

Read the press release here:

Modern Contingent Workforce Strategy

“At GE, we disrupt ourselves – fundamentally rethinking the way we do business, embracing new technology and leaning into talent innovation,” said Dyan Finkhousen, president and CEO of GENIUSLINK™ and Director of Innovation and Advanced Manufacturing for GE. “Our customers engage with talent networks in new ways – often accelerating programs by at least 50 percent and increasing productivity and cost savings. Upwork is an essential partner to make that happen at scale.”
Hear more from GENIUSLINK and Upwork at Work Rebooted at 2pm PT on February 12th in San Francisco, CA: .

The HeadHealthTECH IV webinar recording is available here !  Click the link to listen on-demand and hear from challenge sponsors, Dr. Barry Myers, Director of Innovation at Duke University’s Clinical and Translational Science Institute (Duke CTSI), and Jennifer Langton, Vice President of Health and Safety at the National Football League (NFL), as well as TECH Challenge II Winner showcases (Hitgard, Windpact and 2nd Skull)!

As a reminder, HeadHealthTECH Challenge IV focuses on improvements in football protective equipment including helmets and related technologies, turf systems, shoulder and other pads, and more. Proposals are being accepted now through January 10, 2018. Learn more about the series at

Serial Disruption and Experimentation

GENIUSLINK’s own “serial disruptor” Dyan Finkhousen teaching people not be afraid to experiment at the TechServe Alliance annual conference in November.  Blogger Lauren Jones shares her takeaways…

Football season is in full swing–and the NFL is also driving great initiatives off the field!  And, now, it’s officially a wonderful time of year… because the next HeadHealthTECH webinar has arrived!

Please join Dr. Barry Myers, Director of Innovation at Duke University’s Clinical and Translational Science Institute (Duke CTSI), on December 12, 2017 at 11:00am ET for an interactive discussion on HeadHealthTECH Challenge IV.


What does the future of work look like? At GE, it’s not the traditional, hierarchical model where workers clock in each day performing set tasks. Instead, GE is exchanging this outdated model for one based on flexible, project-based teams.

Read the full article here: 

(Photo Credit: Upwork)

GENIUSLINK™ has developed the world’s most advanced talent cloud services, dramatically improving cost and speed for GE teams and customers.

At a conference of our peers last night, GE’s GENIUSLINK model was recognized as the industry standard for driving financial impact through innovation.

What has always distinguished our model from our peers, is that we know the key to success isn’t simply to innovate.

To drive out-sized results, leaders need to execute business activities in a very different way. They still need to leverage automation, people, and companies to execute get work done.  What’s different, and essential, is that leaders now need to think of all their resources as a ‘talent stack’, and add the new layers of experts available through tools like gig, crowdsourcing and open innovation. They need to do this on a sustained basis, not through ad-hoc projects.  Designing and managing work in this way requires a different skill set.  So most importantly, they need GENIUSLINK.

A few of our more progressive teams get this, and achieving out-sized results.  Among these, GE Additive stands out – showing others not only what the future of manufacturing, but also the future of work, looks like.  A big thank you to Josh Mook for sharing the GE Additive story at this conference.

We’re proud to help these teams achieve greater success, and we’re honored by this recognition from our peers.

Read the announcement here: